Urological Oncology Unit, Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, C/Cartagena, 340-350, 08025, Barcelona, Spain.
Department of Urology, Mayo Clinic, Scottsdale, USA.
World J Urol. 2019 Jan;37(1):85-93. doi: 10.1007/s00345-018-2484-3. Epub 2018 Sep 20.
To provide a comprehensive overview and update of the joint consultation of the International Consultation on Urological Diseases (ICUD) and Société Internationale d'Urologie on Bladder Cancer Urinary Diversion (UD).
A detailed analysis of the literature was conducted reporting on the different modalities of UD. For this updated publication, an exhaustive search was conducted in PubMed for recent relevant papers published between October 2013 and August 2018. Via this search, a total of 438 references were identified and 52 of them were finally eligible for analysis. An international, multidisciplinary expert committee evaluated and graded the data according to the Oxford System of Evidence-based Medicine.
The incidence of early complications has been reported retrospectively in the range of 20-57%. Unfortunately, only a few randomized controlled studies exist within the field of UD. Consequently, almost all studies used in this report are of level 3-4 evidence including expert opinion based on "first principles" research.
Complications rates overall following RC and UD are significant, and when strict reporting criteria are incorporated, they are much higher than previously published. Complications can occur up to 20 years after surgery, emphasizing the need for lifelong follow-up. Progress has been made to prevent complications implementing robotic surgery and fast track protocols. Preoperative patient information, patient selection, surgical techniques, and careful postoperative follow-up are the cornerstones to achieve good results.
提供国际泌尿外科疾病咨询(ICUD)和国际泌尿学会关于膀胱癌尿流改道术(UD)联合咨询的全面概述和更新。
对文献进行了详细分析,报告了 UD 的不同方式。对于本次更新的出版物,在 PubMed 中进行了全面搜索,以查找 2013 年 10 月至 2018 年 8 月之间发表的最近相关论文。通过该搜索,共确定了 438 个参考文献,其中 52 个最终符合分析条件。一个国际多学科专家委员会根据牛津循证医学系统评估和分级数据。
早期并发症的发生率已在 20-57%的范围内进行了回顾性报告。不幸的是,UD 领域几乎没有随机对照研究。因此,本报告中使用的几乎所有研究均为 3-4 级证据,包括基于“第一原则”研究的专家意见。
RC 和 UD 后的并发症发生率很高,当纳入严格的报告标准时,它们比以前发表的要高得多。并发症可在手术后 20 年内发生,强调需要终身随访。通过采用机器人手术和快速通道方案,在预防并发症方面取得了进展。术前患者信息、患者选择、手术技术和仔细的术后随访是实现良好结果的基石。